Is compounded semaglutide safe?

Generally safe from licensed US compounding pharmacies under FDA regulations. Not FDA-approved. Verify pharmacy is licensed and discuss with your provider.

Is compounded semaglutide the same as Wegovy?

No. Wegovy is FDA-approved by Novo Nordisk. Compounded is not FDA-approved. Same active ingredient but formulation and quality may differ.

How much cheaper is compounded semaglutide?

Compounded: $179-$399/month. Wegovy: $1,300 retail or $149 NovoCare pen. Similar to NovoCare but much cheaper than retail.

Will compounded GLP-1 medications be banned?

Compounding is permitted during shortages. As shortages resolve, FDA may restrict. Not banned outright but availability may change.

Does compounded semaglutide work as well as Wegovy?

No head-to-head trials. Same active ingredient, so expected to be similar. Anecdotal reports show comparable weight loss. Wegovy has proven STEP trial data.

Should I choose compounded or brand-name GLP-1?

Brand-name if you want FDA-approved with proven data and insurance coverage. Compounded if no insurance, want lower cost, comfortable with non-FDA-approved. Discuss with provider.

Is compounded semaglutide the same as Wegovy?

No. Wegovy is FDA-approved semaglutide manufactured by Novo Nordisk with proven safety and efficacy data. Compounded semaglutide is produced by compounding pharmacies and is not FDA-approved. The active ingredient is the same, but the formulation, purity, and quality may differ. Compounded versions cannot legally claim equivalence to Wegovy.

How much cheaper is compounded semaglutide?

Compounded semaglutide via telehealth costs $179-$399/month. Brand-name Wegovy costs $1,300/month retail or $149/month via NovoCare cash-pay pen. So compounded is similar to the NovoCare pen price but much cheaper than retail. Compounded tirzepatide ($249-$449) is cheaper than Zepbound retail ($1,050) but similar to LillyDirect vials ($299-$449).

Will compounded GLP-1 medications be banned?

Compounding is permitted under FDA regulations when brand-name drugs are in shortage. As shortages resolve, the FDA may restrict or end compounding of specific GLP-1s. The FDA has already issued warning letters to companies making false claims. Availability may change, but compounding is not being banned outright.

Does compounded semaglutide work as well as Wegovy?

There are no head-to-head clinical trials comparing compounded semaglutide to Wegovy. Since the active ingredient is the same, efficacy is expected to be similar, but quality and absorption may vary. Anecdotal reports suggest comparable weight loss, but formal data is lacking. Brand-name Wegovy has proven efficacy from the STEP trials.

Should I choose compounded or brand-name GLP-1?

Choose brand-name if you want FDA-approved medication with proven safety data and your insurance covers it. Choose compounded if you do not have insurance, want lower cost, and are comfortable with a non-FDA-approved product from a licensed pharmacy. Always discuss with your provider. See our GLP-1 Cost Guide for pricing details.

Compounded vs Brand-Name GLP-1: Safety, Cost, Efficacy Compared 2026

Compounded vs brand-name GLP-1: quick comparison

Feature	Brand-name (Wegovy/Zepbound)	Compounded (semaglutide/tirzepatide)
FDA-approved	Yes	No
Clinical trial data	STEP, SURMOUNT trials	Limited/no head-to-head data
Manufactured by	Novo Nordisk / Eli Lilly	Licensed compounding pharmacies
Cost per month	$149-$1,300 (Wegovy) / $299-$1,050 (Zepbound)	$179-$399 (semaglutide) / $249-$449 (tirzepatide)
Insurance coverage	Yes (with prior auth)	No (cash-pay only)
Quality control	FDA-regulated manufacturing	USP 797/795 standards
Availability	Pharmacies + manufacturer programs	Telehealth programs only
Active ingredient	Semaglutide / tirzepatide	Same active ingredient

What is compounded GLP-1 medication?

Compounded medications are custom-made by compounding pharmacies rather than mass-produced by pharmaceutical manufacturers. Under FDA regulations, compounding pharmacies can produce versions of commercially available drugs when those drugs are on the FDA shortage list.

Since semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) have experienced shortages since 2022, compounding pharmacies have been producing compounded versions. These are typically sold through telehealth programs like NewSelf, Mochi Health, and Hims & Hers.

Safety considerations

Brand-name safety

Wegovy and Zepbound have undergone rigorous FDA premarket review with large clinical trials (STEP, SURMOUNT). Their safety profiles are well-characterized across hundreds of thousands of patients.

Compounded safety

Compounded GLP-1 medications are not FDA-approved and have not undergone premarket review. However, if produced by a licensed US compounding pharmacy following USP standards, they are generally considered safe. Key risks:

No FDA oversight: Quality may vary between pharmacies
No clinical trial data: Efficacy and safety not formally studied
FDA warnings: The FDA has issued warning letters to companies making false equivalence claims or selling unapproved versions
Salt forms: Some compounding pharmacies previously used semaglutide salts (not the same as the active ingredient in Wegovy). The FDA has banned these.

Always verify: the pharmacy is licensed in your state, the product contains semaglutide (not a salt form), and your provider is monitoring your progress.

Cost comparison

Option	Monthly cost	Insurance?	Best for
Wegovy (NovoCare pen)	$149	No (cash-pay)	Want FDA-approved, no insurance
Wegovy (with insurance)	$0-$25	Yes	Have commercial insurance
Zepbound (LillyDirect vials)	$299-$449	No (cash-pay)	Want tirzepatide, no insurance
Compounded semaglutide	$179-$399	No	Budget option, no insurance
Compounded tirzepatide	$249-$449	No	Want tirzepatide, no insurance

Full pricing details in our GLP-1 Cost Guide 2026, Wegovy cost guide, and Zepbound cost guide.

FDA regulations and the future of compounded GLP-1s

The FDA permits compounding of drugs on the shortage list. As of August 2026:

Most Wegovy doses are back in stock — compounding of semaglutide may be restricted
Some Ozempic doses remain in shortage — compounding may continue
Zepbound and Mounjaro availability has improved
The FDA issued warning letters to 30 telehealth companies in March 2026 for false claims
Novo Nordisk has taken legal action against clinics using "semaglutide" to market compounded products

See our GLP-1 shortage 2026 update for current availability.

Not sure which GLP-1 option is right for you?

A US-licensed provider can help you choose based on your budget and health profile.

Check eligibility

Which should you choose?

Choose brand-name if:

You want FDA-approved medication with proven safety data
Your insurance covers Wegovy or Zepbound
You can access NovoCare pen ($149) or LillyDirect vials ($299-$449)
You want the assurance of FDA-regulated manufacturing

Choose compounded if:

You do not have insurance and want the lowest cost
You are comfortable with a non-FDA-approved product
You use a reputable telehealth program with a licensed pharmacy
Brand-name options are unavailable in your area

See our best telehealth GLP-1 guide for provider comparisons.

Related guides

Medical disclaimer: This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting any medication.

Compounded vs Brand-Name GLP-1: Safety, Cost & Efficacy Compared

Start your GLP-1 weight-loss plan today